LAVA Therapeutics NV (LVTX) Q1 2025 Earnings

28MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.46
-0.31
-0.17
-0.02

Details

Expected EPS
-0.295
Actual EPS
-0.14
Surprise EPS
0.15
Surprise Percent
+52.54%

Description

LAVA Therapeutics NV (LVTX) has reported earnings of -0.14 per share for Q1 2025.

0 Comments

Share your thoughts